ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Botanical Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-13I9292
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Botanical Drug Market Size Status and Forecast 2022
BUY CHAPTERS

Global Botanical Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-13I9292
Report
June 2025
Pages:134
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica SE
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals

Botanical Drug Market Size

In 2024, the global market size of Botanical Drug was estimated to be worth US$ 39810 million and is forecast to reach approximately US$ 54940 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.

Botanical Drug Market

Botanical Drug Market

A botanical drug product is intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in humans.
A botanical drug product consists of vegetable materials, which may include plant materials, algae, macroscopic fungi, or combinations thereof.
A botanical drug product may be available as (but not limited to) a solution, powder, tablet, capsule, elixir, topical, or injection.
Botanical drug products often have unique features, for example, complex mixtures, lack of a distinct active ingredient, and substantial prior human use. Fermentation products and highly purified or chemically modified botanical substances are not considered botanical drug products.
Global 5 largest manufacturers of Botanical Drug are Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe and Tong Ren Tang, which make up about 30%.
China is the largest market, with a share over 60%. In terms of product type, OTC occupy the largest share of the total market, over 60%. And in terms of application, the largest application is Cardiovascular, followed by Respiratory System and Tumor.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Botanical Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Botanical Drug.
The Botanical Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Botanical Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Botanical Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Botanical Drug Market Report

Report Metric Details
Report Name Botanical Drug Market
CAGR 4.8%
Segment by Type
  • Prescription Drug
  • OTC
Segment by Application
  • Cardiovascular
  • Tumor
  • Respiratory System
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao, Tasly Holding Group, Bionorica Se, Huarun 999, Taiji, Weleda, Kwangdong, GW Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Botanical Drug in global and regional level.
  • Chapter 3: Detailed analysis of Botanical Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Botanical Drug revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Botanical Drug Market share by region?

Ans: China is the largest market, with a share over 60%.

What is the Botanical Drug Market share by type?

Ans: In terms of product type, OTC occupy the largest share of the total market, over 60%.

Who are the main players in the Botanical Drug Market report?

Ans: The main players in the Botanical Drug Market are Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao, Tasly Holding Group, Bionorica Se, Huarun 999, Taiji, Weleda, Kwangdong, GW Pharmaceuticals

What are the Application segmentation covered in the Botanical Drug Market report?

Ans: The Applications covered in the Botanical Drug Market report are Cardiovascular, Tumor, Respiratory System, Other

What are the Type segmentation covered in the Botanical Drug Market report?

Ans: The Types covered in the Botanical Drug Market report are Prescription Drug, OTC

1 Study Coverage
1.1 Botanical Drug Product Introduction
1.2 Market by Type
1.2.1 Global Botanical Drug Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Prescription Drug
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Botanical Drug Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Cardiovascular
1.3.3 Tumor
1.3.4 Respiratory System
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Botanical Drug Market Size Estimates and Forecasts
2.2 Botanical Drug Market Size by Region: 2024 Versus 2031
2.2.1 Global Botanical Drug Revenue by Region: 2020-2025
2.2.2 Global Botanical Drug Revenue Forecast by Region (2026-2031)
2.2.3 Global Botanical Drug Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Botanical Drug Revenue by Type (2020-2031)
3.1.2 Global Botanical Drug Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Botanical Drug Revenue by Application (2020-2031)
3.2.2 Global Botanical Drug Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Prescription Drug of Botanical Drug Revenue Market Share by Application
3.3.2 OTC of Botanical Drug Revenue Market Share by Application
4 Global Botanical Drug by Company
4.1 Global Botanical Drug Revenue by Company (2020-2025)
4.2 Global Botanical Drug Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Botanical Drug Companies around the World: Ranking by Revenue
4.3.2 Global Botanical Drug Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Botanical Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Botanical Drug Companies Headquarters & Product Type
4.4.1 Global Botanical Drug Companies Headquarters
4.4.2 Date of International Companies Enter into Botanical Drug Market
4.4.3 Global Botanical Drug Companies Product & Service
4.4.4 Prescription Drug Revenue Market Share of Botanical Drug by Company
4.4.5 OTC Revenue Market Share of Botanical Drug by Company
4.5 Global Botanical Drug Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Buchang Pharmaceuticals
5.1.1 Buchang Pharmaceuticals Corporation Information
5.1.2 Buchang Pharmaceuticals Description, Business Overview
5.1.3 Buchang Pharmaceuticals Botanical Drug Products Offered
5.1.4 Buchang Pharmaceuticals Botanical Drug Revenue and Gross Margin (2020-2025)
5.1.5 Buchang Pharmaceuticals Botanical Drug Revenue by Product in 2024
5.1.6 Buchang Pharmaceuticals Botanical Drug Revenue by Application in 2024
5.1.7 Buchang Pharmaceuticals Botanical Drug Revenue by Geographic Area in 2024
5.1.8 Buchang Pharmaceuticals Recent Developments
5.2 China TCM
5.2.1 China TCM Corporation Information
5.2.2 China TCM Description, Business Overview
5.2.3 China TCM Botanical Drug Products Offered
5.2.4 China TCM Botanical Drug Revenue and Gross Margin (2020-2025)
5.2.5 China TCM Botanical Drug Revenue by Product in 2024
5.2.6 China TCM Botanical Drug Revenue by Application in 2024
5.2.7 China TCM Botanical Drug Revenue by Geographic Area in 2024
5.2.8 China TCM Recent Developments
5.3 Tsumura
5.3.1 Tsumura Corporation Information
5.3.2 Tsumura Description, Business Overview
5.3.3 Tsumura Botanical Drug Products Offered
5.3.4 Tsumura Botanical Drug Revenue and Gross Margin (2020-2025)
5.3.5 Tsumura Botanical Drug Revenue by Product in 2024
5.3.6 Tsumura Botanical Drug Revenue by Application in 2024
5.3.7 Tsumura Botanical Drug Revenue by Geographic Area in 2024
5.3.8 Tsumura Recent Developments
5.4 Schwabe
5.4.1 Schwabe Corporation Information
5.4.2 Schwabe Description, Business Overview
5.4.3 Schwabe Botanical Drug Products Offered
5.4.4 Schwabe Botanical Drug Revenue and Gross Margin (2020-2025)
5.4.5 Schwabe Botanical Drug Revenue by Product in 2024
5.4.6 Schwabe Botanical Drug Revenue by Application in 2024
5.4.7 Schwabe Botanical Drug Revenue by Geographic Area in 2024
5.4.8 Schwabe Recent Developments
5.5 Tong Ren Tang
5.5.1 Tong Ren Tang Corporation Information
5.5.2 Tong Ren Tang Description, Business Overview
5.5.3 Tong Ren Tang Botanical Drug Products Offered
5.5.4 Tong Ren Tang Botanical Drug Revenue and Gross Margin (2020-2025)
5.5.5 Tong Ren Tang Botanical Drug Revenue by Product in 2024
5.5.6 Tong Ren Tang Botanical Drug Revenue by Application in 2024
5.5.7 Tong Ren Tang Botanical Drug Revenue by Geographic Area in 2024
5.5.8 Tong Ren Tang Recent Developments
5.6 Jumpcan Pharmaceutical
5.6.1 Jumpcan Pharmaceutical Corporation Information
5.6.2 Jumpcan Pharmaceutical Description, Business Overview
5.6.3 Jumpcan Pharmaceutical Botanical Drug Products Offered
5.6.4 Jumpcan Pharmaceutical Botanical Drug Revenue and Gross Margin (2020-2025)
5.6.5 Jumpcan Pharmaceutical Botanical Drug Revenue by Product in 2024
5.6.6 Jumpcan Pharmaceutical Botanical Drug Revenue by Application in 2024
5.6.7 Jumpcan Pharmaceutical Botanical Drug Revenue by Geographic Area in 2024
5.6.8 Jumpcan Pharmaceutical Recent Developments
5.7 Guangzhou Baiyunshan Pharmaceutical
5.7.1 Guangzhou Baiyunshan Pharmaceutical Corporation Information
5.7.2 Guangzhou Baiyunshan Pharmaceutical Description, Business Overview
5.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Products Offered
5.7.4 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue and Gross Margin (2020-2025)
5.7.5 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue by Product in 2024
5.7.6 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue by Application in 2024
5.7.7 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue by Geographic Area in 2024
5.7.8 Guangzhou Baiyunshan Pharmaceutical Recent Developments
5.8 Yunnan Baiyao
5.8.1 Yunnan Baiyao Corporation Information
5.8.2 Yunnan Baiyao Description, Business Overview
5.8.3 Yunnan Baiyao Botanical Drug Products Offered
5.8.4 Yunnan Baiyao Botanical Drug Revenue and Gross Margin (2020-2025)
5.8.5 Yunnan Baiyao Botanical Drug Revenue by Product in 2024
5.8.6 Yunnan Baiyao Botanical Drug Revenue by Application in 2024
5.8.7 Yunnan Baiyao Botanical Drug Revenue by Geographic Area in 2024
5.8.8 Yunnan Baiyao Recent Developments
5.9 Tasly Holding Group
5.9.1 Tasly Holding Group Corporation Information
5.9.2 Tasly Holding Group Description, Business Overview
5.9.3 Tasly Holding Group Botanical Drug Products Offered
5.9.4 Tasly Holding Group Botanical Drug Revenue and Gross Margin (2020-2025)
5.9.5 Tasly Holding Group Botanical Drug Revenue by Product in 2024
5.9.6 Tasly Holding Group Botanical Drug Revenue by Application in 2024
5.9.7 Tasly Holding Group Botanical Drug Revenue by Geographic Area in 2024
5.9.8 Tasly Holding Group Recent Developments
5.10 Bionorica Se
5.10.1 Bionorica Se Corporation Information
5.10.2 Bionorica Se Description, Business Overview
5.10.3 Bionorica Se Botanical Drug Products Offered
5.10.4 Bionorica Se Botanical Drug Revenue and Gross Margin (2020-2025)
5.10.5 Bionorica Se Botanical Drug Revenue by Product in 2024
5.10.6 Bionorica Se Botanical Drug Revenue by Application in 2024
5.10.7 Bionorica Se Botanical Drug Revenue by Geographic Area in 2024
5.10.8 Bionorica Se Recent Developments
5.11 Huarun 999
5.11.1 Huarun 999 Corporation Information
5.11.2 Huarun 999 Description, Business Overview
5.11.3 Huarun 999 Botanical Drug Products Offered
5.11.4 Huarun 999 Botanical Drug Revenue and Gross Margin (2020-2025)
5.11.5 Huarun 999 Botanical Drug Revenue by Product in 2024
5.11.6 Huarun 999 Botanical Drug Revenue by Application in 2024
5.11.7 Huarun 999 Botanical Drug Revenue by Geographic Area in 2024
5.11.8 Huarun 999 Recent Developments
5.12 Taiji
5.12.1 Taiji Corporation Information
5.12.2 Taiji Description, Business Overview
5.12.3 Taiji Botanical Drug Products Offered
5.12.4 Taiji Botanical Drug Revenue and Gross Margin (2020-2025)
5.12.5 Taiji Botanical Drug Revenue by Product in 2024
5.12.6 Taiji Botanical Drug Revenue by Application in 2024
5.12.7 Taiji Botanical Drug Revenue by Geographic Area in 2024
5.12.8 Taiji Recent Developments
5.13 Weleda
5.13.1 Weleda Corporation Information
5.13.2 Weleda Description, Business Overview
5.13.3 Weleda Botanical Drug Products Offered
5.13.4 Weleda Botanical Drug Revenue and Gross Margin (2020-2025)
5.13.5 Weleda Botanical Drug Revenue by Product in 2024
5.13.6 Weleda Botanical Drug Revenue by Application in 2024
5.13.7 Weleda Botanical Drug Revenue by Geographic Area in 2024
5.13.8 Weleda Recent Developments
5.14 Kwangdong
5.14.1 Kwangdong Corporation Information
5.14.2 Kwangdong Description, Business Overview
5.14.3 Kwangdong Botanical Drug Products Offered
5.14.4 Kwangdong Botanical Drug Revenue and Gross Margin (2020-2025)
5.14.5 Kwangdong Botanical Drug Revenue by Product in 2024
5.14.6 Kwangdong Botanical Drug Revenue by Application in 2024
5.14.7 Kwangdong Botanical Drug Revenue by Geographic Area in 2024
5.14.8 Kwangdong Recent Developments
5.15 GW Pharmaceuticals
5.15.1 GW Pharmaceuticals Corporation Information
5.15.2 GW Pharmaceuticals Description, Business Overview
5.15.3 GW Pharmaceuticals Botanical Drug Products Offered
5.15.4 GW Pharmaceuticals Botanical Drug Revenue and Gross Margin (2020-2025)
5.15.5 GW Pharmaceuticals Botanical Drug Revenue by Product in 2024
5.15.6 GW Pharmaceuticals Botanical Drug Revenue by Application in 2024
5.15.7 GW Pharmaceuticals Botanical Drug Revenue by Geographic Area in 2024
5.15.8 GW Pharmaceuticals Recent Developments
6 North America
6.1 North America Botanical Drug Market Size YoY Growth 2020-2031
6.2 North America Botanical Drug Market Facts & Figures by Country (2020-2031)
6.3 North America Botanical Drug Revenue by Type (2020-2025)
6.4 North America Botanical Drug Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Botanical Drug Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Botanical Drug Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Botanical Drug Revenue by Type (2020-2025)
7.4 Asia-Pacific Botanical Drug Revenue by Application (2020-2025)
8 Europe
8.1 Europe Botanical Drug Market Size YoY Growth 2020-2031
8.2 Europe Botanical Drug Market Facts & Figures by Country (2020-2031)
8.3 Europe Botanical Drug Revenue by Type (2020-2025)
8.4 Europe Botanical Drug Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Botanical Drug Market Size YoY Growth 2020-2031
9.2 Latin America Botanical Drug Market Facts & Figures by Country (2020-2031)
9.3 Latin America Botanical Drug Revenue by Type (2020-2025)
9.4 Latin America Botanical Drug Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Botanical Drug Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Botanical Drug Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Botanical Drug Revenue by Type (2020-2025)
10.4 Middle East and Africa Botanical Drug Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Botanical Drug Supply Chain Analysis
11.2 Botanical Drug Key Raw Materials and Upstream Suppliers
11.3 Botanical Drug Clients Analysis
11.4 Botanical Drug Sales Channel and Sales Model Analysis
11.4.1 Botanical Drug Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Botanical Drug Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Botanical Drug Distributors
12 Botanical Drug Market Dynamics
12.1 Botanical Drug Industry Trends
12.2 Botanical Drug Market Drivers
12.3 Botanical Drug Market Challenges
12.4 Botanical Drug Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica SE
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals
List of Tables
 Table 1. Global Botanical Drug Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Botanical Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Botanical Drug Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Botanical Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Botanical Drug Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Botanical Drug Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Botanical Drug Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Botanical Drug Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Botanical Drug Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Botanical Drug Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Botanical Drug Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Botanical Drug Players by Revenue (US$ Million) in 2024
 Table 13. Global Botanical Drug Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Botanical Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Botanical Drug as of 2024)
 Table 15. Global Botanical Drug Companies Headquarters
 Table 16. Date of International Companies Enter into Botanical Drug Market
 Table 17. Global Botanical Drug Companies Product & Service
 Table 18. Global Botanical Drug Mergers & Acquisitions, Expansion Plans
 Table 19. Buchang Pharmaceuticals Corporation Information
 Table 20. Buchang Pharmaceuticals Description and Business Overview
 Table 21. Buchang Pharmaceuticals Botanical Drug Product
 Table 22. Buchang Pharmaceuticals Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Buchang Pharmaceuticals Revenue Proportion of Botanical Drug by Product in 2024
 Table 24. Buchang Pharmaceuticals Revenue Proportion of Botanical Drug by Application in 2024
 Table 25. Buchang Pharmaceuticals Revenue Proportion of Botanical Drug by Geographic Area in 2024
 Table 26. Buchang Pharmaceuticals Recent Developments
 Table 27. China TCM Corporation Information
 Table 28. China TCM Description and Business Overview
 Table 29. China TCM Botanical Drug Product
 Table 30. China TCM Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. China TCM Revenue Proportion of Botanical Drug by Product in 2024
 Table 32. China TCM Revenue Proportion of Botanical Drug by Application in 2024
 Table 33. China TCM Revenue Proportion of Botanical Drug by Geographic Area in 2024
 Table 34. China TCM Recent Developments
 Table 35. Tsumura Corporation Information
 Table 36. Tsumura Description and Business Overview
 Table 37. Tsumura Botanical Drug Product
 Table 38. Tsumura Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. Tsumura Revenue Proportion of Botanical Drug by Product in 2024
 Table 40. Tsumura Revenue Proportion of Botanical Drug by Application in 2024
 Table 41. Tsumura Revenue Proportion of Botanical Drug by Geographic Area in 2024
 Table 42. Tsumura Recent Developments
 Table 43. Schwabe Corporation Information
 Table 44. Schwabe Description and Business Overview
 Table 45. Schwabe Botanical Drug Product
 Table 46. Schwabe Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Schwabe Revenue Proportion of Botanical Drug by Product in 2024
 Table 48. Schwabe Revenue Proportion of Botanical Drug by Application in 2024
 Table 49. Schwabe Revenue Proportion of Botanical Drug by Geographic Area in 2024
 Table 50. Schwabe Recent Developments
 Table 51. Tong Ren Tang Corporation Information
 Table 52. Tong Ren Tang Description and Business Overview
 Table 53. Tong Ren Tang Botanical Drug Product
 Table 54. Tong Ren Tang Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. Tong Ren Tang Revenue Proportion of Botanical Drug by Product in 2024
 Table 56. Tong Ren Tang Revenue Proportion of Botanical Drug by Application in 2024
 Table 57. Tong Ren Tang Revenue Proportion of Botanical Drug by Geographic Area in 2024
 Table 58. Tong Ren Tang Recent Developments
 Table 59. Jumpcan Pharmaceutical Corporation Information
 Table 60. Jumpcan Pharmaceutical Description and Business Overview
 Table 61. Jumpcan Pharmaceutical Botanical Drug Product
 Table 62. Jumpcan Pharmaceutical Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. Jumpcan Pharmaceutical Revenue Proportion of Botanical Drug by Product in 2024
 Table 64. Jumpcan Pharmaceutical Revenue Proportion of Botanical Drug by Application in 2024
 Table 65. Jumpcan Pharmaceutical Revenue Proportion of Botanical Drug by Geographic Area in 2024
 Table 66. Jumpcan Pharmaceutical Recent Developments
 Table 67. Guangzhou Baiyunshan Pharmaceutical Corporation Information
 Table 68. Guangzhou Baiyunshan Pharmaceutical Description and Business Overview
 Table 69. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product
 Table 70. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. Guangzhou Baiyunshan Pharmaceutical Revenue Proportion of Botanical Drug by Product in 2024
 Table 72. Guangzhou Baiyunshan Pharmaceutical Revenue Proportion of Botanical Drug by Application in 2024
 Table 73. Guangzhou Baiyunshan Pharmaceutical Revenue Proportion of Botanical Drug by Geographic Area in 2024
 Table 74. Guangzhou Baiyunshan Pharmaceutical Recent Developments
 Table 75. Yunnan Baiyao Corporation Information
 Table 76. Yunnan Baiyao Description and Business Overview
 Table 77. Yunnan Baiyao Botanical Drug Product
 Table 78. Yunnan Baiyao Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. Yunnan Baiyao Revenue Proportion of Botanical Drug by Product in 2024
 Table 80. Yunnan Baiyao Revenue Proportion of Botanical Drug by Application in 2024
 Table 81. Yunnan Baiyao Revenue Proportion of Botanical Drug by Geographic Area in 2024
 Table 82. Yunnan Baiyao Recent Developments
 Table 83. Tasly Holding Group Corporation Information
 Table 84. Tasly Holding Group Description and Business Overview
 Table 85. Tasly Holding Group Botanical Drug Product
 Table 86. Tasly Holding Group Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. Tasly Holding Group Revenue Proportion of Botanical Drug by Product in 2024
 Table 88. Tasly Holding Group Revenue Proportion of Botanical Drug by Application in 2024
 Table 89. Tasly Holding Group Revenue Proportion of Botanical Drug by Geographic Area in 2024
 Table 90. Tasly Holding Group Recent Developments
 Table 91. Bionorica Se Corporation Information
 Table 92. Bionorica Se Description and Business Overview
 Table 93. Bionorica Se Botanical Drug Product
 Table 94. Bionorica Se Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 95. Bionorica Se Revenue Proportion of Botanical Drug by Product in 2024
 Table 96. Bionorica Se Revenue Proportion of Botanical Drug by Application in 2024
 Table 97. Bionorica Se Revenue Proportion of Botanical Drug by Geographic Area in 2024
 Table 98. Bionorica Se Recent Developments
 Table 99. Huarun 999 Corporation Information
 Table 100. Huarun 999 Description and Business Overview
 Table 101. Huarun 999 Botanical Drug Product
 Table 102. Huarun 999 Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Huarun 999 Revenue Proportion of Botanical Drug by Product in 2024
 Table 104. Huarun 999 Revenue Proportion of Botanical Drug by Application in 2024
 Table 105. Huarun 999 Revenue Proportion of Botanical Drug by Geographic Area in 2024
 Table 106. Huarun 999 Recent Developments
 Table 107. Taiji Corporation Information
 Table 108. Taiji Description and Business Overview
 Table 109. Taiji Botanical Drug Product
 Table 110. Taiji Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 111. Taiji Revenue Proportion of Botanical Drug by Product in 2024
 Table 112. Taiji Revenue Proportion of Botanical Drug by Application in 2024
 Table 113. Taiji Revenue Proportion of Botanical Drug by Geographic Area in 2024
 Table 114. Taiji Recent Developments
 Table 115. Weleda Corporation Information
 Table 116. Weleda Description and Business Overview
 Table 117. Weleda Botanical Drug Product
 Table 118. Weleda Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 119. Weleda Revenue Proportion of Botanical Drug by Product in 2024
 Table 120. Weleda Revenue Proportion of Botanical Drug by Application in 2024
 Table 121. Weleda Revenue Proportion of Botanical Drug by Geographic Area in 2024
 Table 122. Weleda Recent Developments
 Table 123. Kwangdong Corporation Information
 Table 124. Kwangdong Description and Business Overview
 Table 125. Kwangdong Botanical Drug Product
 Table 126. Kwangdong Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 127. Kwangdong Revenue Proportion of Botanical Drug by Product in 2024
 Table 128. Kwangdong Revenue Proportion of Botanical Drug by Application in 2024
 Table 129. Kwangdong Revenue Proportion of Botanical Drug by Geographic Area in 2024
 Table 130. Kwangdong Recent Developments
 Table 131. GW Pharmaceuticals Corporation Information
 Table 132. GW Pharmaceuticals Description and Business Overview
 Table 133. GW Pharmaceuticals Botanical Drug Product
 Table 134. GW Pharmaceuticals Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 135. GW Pharmaceuticals Revenue Proportion of Botanical Drug by Product in 2024
 Table 136. GW Pharmaceuticals Revenue Proportion of Botanical Drug by Application in 2024
 Table 137. GW Pharmaceuticals Revenue Proportion of Botanical Drug by Geographic Area in 2024
 Table 138. GW Pharmaceuticals Recent Developments
 Table 139. North America Botanical Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 140. North America Botanical Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 141. North America Botanical Drug Revenue by Type (2020-2025) & (US$ Million)
 Table 142. North America Botanical Drug Revenue by Application (2020-2025) & (US$ Million)
 Table 143. Asia-Pacific Botanical Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 144. Asia-Pacific Botanical Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 145. Asia-Pacific Botanical Drug Revenue by Type (2020-2025) & (US$ Million)
 Table 146. Asia-Pacific Botanical Drug Revenue by Application (2020-2025) & (US$ Million)
 Table 147. Europe Botanical Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 148. Europe Botanical Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 149. Europe Botanical Drug Revenue by Type (2020-2025) & (US$ Million)
 Table 150. Europe Botanical Drug Revenue by Application (2020-2025) & (US$ Million)
 Table 151. Latin America Botanical Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 152. Latin America Botanical Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 153. Latin America Botanical Drug Revenue by Type (2020-2025) & (US$ Million)
 Table 154. Latin America Botanical Drug Revenue by Application (2020-2025) & (US$ Million)
 Table 155. Middle East and Africa Botanical Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 156. Middle East and Africa Botanical Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 157. Middle East and Africa Botanical Drug Revenue by Type (2020-2025) & (US$ Million)
 Table 158. Middle East and Africa Botanical Drug Revenue by Application (2020-2025) & (US$ Million)
 Table 159. Botanical Drug Key Raw Materials, Industry Status and Trend
 Table 160. Botanical Drug Key Raw Materials and Upstream Suppliers
 Table 161. Botanical Drug Clients Status and Trend
 Table 162. Botanical Drug Typical Clients
 Table 163. Botanical Drug Distributors
 Table 164. Botanical Drug Market Trends
 Table 165. Botanical Drug Market Drivers
 Table 166. Botanical Drug Market Challenges
 Table 167. Botanical Drug Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources


List of Figures
 Figure 1. Botanical Drug Product Picture
 Figure 2. Global Botanical Drug Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Botanical Drug Revenue Market Share by Type in 2024 & 2031
 Figure 4. Prescription Drug Product Picture
 Figure 5. OTC Product Picture
 Figure 6. Global Botanical Drug Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Botanical Drug Revenue Market Share by Application in 2024 & 2031
 Figure 8. Cardiovascular
 Figure 9. Tumor
 Figure 10. Respiratory System
 Figure 11. Other
 Figure 12. Botanical Drug Report Years Considered
 Figure 13. Global Botanical Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Botanical Drug Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Botanical Drug Market Size Market Share by Region: 2024 Versus 2031
 Figure 16. Global Botanical Drug Revenue Market Share by Region (2020-2031)
 Figure 17. Global Botanical Drug Revenue Market Share Forecast by Type (2020-2031)
 Figure 18. Global Botanical Drug Revenue Market Share Forecast by Application (2020-2031)
 Figure 19. Prescription Drug of Botanical Drug Revenue Market Share by Application, 2024 VS 2031
 Figure 20. OTC of Botanical Drug Revenue Market Share by Application, 2024 VS 2031
 Figure 21. Botanical Drug Revenue Share by Company (2024)
 Figure 22. Botanical Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Prescription Drug Revenue Proportion by Company in 2024
 Figure 24. OTC Revenue Proportion by Company in 2024
 Figure 25. North America Botanical Drug Revenue 2020-2031 (US$ Million)
 Figure 26. North America Botanical Drug Revenue Market Share by Type (2020-2025)
 Figure 27. North America Botanical Drug Revenue Market Share by Application (2020-2025)
 Figure 28. Asia-Pacific Botanical Drug Revenue 2020-2031 (US$ Million)
 Figure 29. Asia-Pacific Botanical Drug Revenue Market Share by Region (2020-2031)
 Figure 30. Asia-Pacific Botanical Drug Revenue Market Share by Type (2020-2025)
 Figure 31. Asia-Pacific Botanical Drug Revenue Market Share by Application (2020-2025)
 Figure 32. Europe Botanical Drug Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 33. Europe Botanical Drug Revenue Market Share by Country (2020-2031)
 Figure 34. Europe Botanical Drug Revenue Market Share by Type (2020-2025)
 Figure 35. Europe Botanical Drug Revenue Market Share by Application (2020-2025)
 Figure 36. Latin America Botanical Drug Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 37. Latin America Botanical Drug Revenue Market Share by Country (2020-2031)
 Figure 38. Latin America Botanical Drug Revenue Market Share by Type (2020-2025)
 Figure 39. Latin America Botanical Drug Revenue Market Share by Application (2020-2025)
 Figure 40. Middle East and Africa Botanical Drug Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 41. Middle East and Africa Botanical Drug Revenue Market Share by Country (2020-2031)
 Figure 42. Middle East and Africa Botanical Drug Revenue Market Share by Type (2020-2025)
 Figure 43. Middle East and Africa Botanical Drug Revenue Market Share by Application (2020-2025)
 Figure 44. Botanical Drug Supply Chain (Upstream and Downstream Market)
 Figure 45. Global Production Market Share of Botanical Drug Raw Materials by Region in 2024
 Figure 46. Botanical Drug Distribution Channels
 Figure 47. Global Botanical Drug Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 48. Global Botanical Drug Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 49. Bottom-up and Top-down Approaches for This Report
 Figure 50. Data Triangulation
 Figure 51. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Botanical and Plant Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Botanical and Herbal Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Botanical Medicine Market Research Report 2024
Botanical and Plant Derivative Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Botanical Supplement and Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plant Derivative Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Botanical Dietary Supplement Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plant Extract Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Plant Based Supplement Market Research Report 2024
Global Herbal Medicinal Products Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Botanical Extracts Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global OTC Herbal and Traditional Medicines Market Insights Forecast to 2030
Global Botanical Plant Derived Drug Market Research Report 2025
Global Herbal Supplements and Medicine Market Research Report 2024
Global Botanical Ingredient Market Research Report 2024
Global Botanical Sugar Market Research Report 2024
Global Dietary Supplement Ingredient Market Research Report 2024
Global Botanical Infused Drink Market Research Report 2024
Global Herbal Medicine Market Insights Forecast to 2030
Global Plant based Beauty Products Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions